•For the first time, the FDA has approved a clinical trial of a secular, ritual-based group facilitation model for psychedelic therapy, demonstrating its safety and efficacy. •A study on psilocybin therapy for metastatic cancer patients with anxiety and depression showed statistically and clinically significant decreases...
Have you ever thought about how your environment contributes to your mood? The relationships we maintain, communities we engage with, news we read about, and even workplace culture all influence emotional wellbeing. If we want to be better people, it’s our responsibility to surround ourselves...
Could the psychedelic substance ibogaine have the potential to not just alter consciousness, but to physically repair and restore the brain in debilitating conditions like Multiple Sclerosis, Traumatic Brain Injury, and Opioid Use Disorder? Synopsis : Emerging research is exploring the radical idea that ibogaine,...
Can psilocybin-assisted therapy help people with treatment-resistant depression—particularly those struggling with anhedonia, the inability to feel pleasure—find joy again? Synopsis: For those battling depression that hasn't responded to traditional treatments, the world can seem gray and lifeless. A core, often overlooked, symptom of this is...